Candy Robinson

2.1k total citations
30 papers, 1.6k citations indexed

About

Candy Robinson is a scholar working on Molecular Biology, Cell Biology and Surgery. According to data from OpenAlex, Candy Robinson has authored 30 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 7 papers in Cell Biology and 4 papers in Surgery. Recurrent topics in Candy Robinson's work include Angiogenesis and VEGF in Cancer (9 papers), Cholesterol and Lipid Metabolism (4 papers) and Muscle Physiology and Disorders (3 papers). Candy Robinson is often cited by papers focused on Angiogenesis and VEGF in Cancer (9 papers), Cholesterol and Lipid Metabolism (4 papers) and Muscle Physiology and Disorders (3 papers). Candy Robinson collaborates with scholars based in United States, Australia and Italy. Candy Robinson's co-authors include Bruce Ruggeri, Peter J. Gillies, Roseanne S. Wexler, Janet S. Kerr, Melpo Christofidou‐Solomidou, Horace M. DeLisser, Joseph A. Madri, Cecília Garlanda, Robert M. Strieter and Steven Μ. Albelda and has published in prestigious journals such as Genes & Development, The Journal of Cell Biology and Blood.

In The Last Decade

Candy Robinson

30 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Candy Robinson United States 17 890 232 198 175 175 30 1.6k
Christian Chabert Switzerland 20 1.8k 2.0× 374 1.6× 150 0.8× 92 0.5× 283 1.6× 22 2.5k
Elisa Ciraolo Italy 22 884 1.0× 173 0.7× 168 0.8× 172 1.0× 228 1.3× 32 1.5k
Trevor R. Walker United Kingdom 16 739 0.8× 200 0.9× 96 0.5× 167 1.0× 126 0.7× 22 1.4k
Robert T. Dorsam United States 18 1.3k 1.4× 432 1.9× 130 0.7× 567 3.2× 172 1.0× 22 2.6k
Nancy Lewis Baenziger United States 19 753 0.8× 138 0.6× 218 1.1× 505 2.9× 143 0.8× 30 2.0k
Arnaud Monvoisin France 21 781 0.9× 263 1.1× 68 0.3× 127 0.7× 115 0.7× 31 1.6k
Peter P. Sayeski United States 27 980 1.1× 575 2.5× 314 1.6× 161 0.9× 79 0.5× 76 1.8k
Françoise Bono France 29 1.3k 1.5× 380 1.6× 252 1.3× 403 2.3× 272 1.6× 65 2.7k
Lydia Puricelli Argentina 26 901 1.0× 551 2.4× 128 0.6× 78 0.4× 183 1.0× 68 1.8k
Pierre‐Alain Vitte United States 11 821 0.9× 274 1.2× 102 0.5× 69 0.4× 74 0.4× 14 1.5k

Countries citing papers authored by Candy Robinson

Since Specialization
Citations

This map shows the geographic impact of Candy Robinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Candy Robinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Candy Robinson more than expected).

Fields of papers citing papers by Candy Robinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Candy Robinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Candy Robinson. The network helps show where Candy Robinson may publish in the future.

Co-authorship network of co-authors of Candy Robinson

This figure shows the co-authorship network connecting the top 25 collaborators of Candy Robinson. A scholar is included among the top collaborators of Candy Robinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Candy Robinson. Candy Robinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Underiner, Ted L., Bruce Ruggeri, Lisa D. Aimone, et al.. (2008). TIE-2/VEGF-R2 SAR and in vitro activity of C3-acyl dihydroindazolo[5,4-a]pyrrolo[3,4-c]carbazole analogs. Bioorganic & Medicinal Chemistry Letters. 18(7). 2368–2372. 8 indexed citations
2.
Zulli, Allison L., Edward R. Bacon, Ted L. Underiner, et al.. (2008). Design and synthesis of dihydroindazolo[5,4-a]pyrrolo[3,4-c]carbazole oximes as potent dual inhibitors of TIE-2 and VEGF-R2 receptor tyrosine kinases. Bioorganic & Medicinal Chemistry Letters. 18(6). 1916–1921. 15 indexed citations
3.
Ruggeri, Bruce, Ted L. Underiner, Diane E. Gingrich, et al.. (2007). CEP-11981: A potent TIE-2/Pan-VEGF-R inhibitor with broad kinase inhibitory activity exhibits significant antitumor and antiangiogenic efficacy in preclinical tumor models. Molecular Cancer Therapeutics. 6. 2 indexed citations
4.
Zulli, Allison L., Thelma S. Angeles, Shi Yang, et al.. (2006). Novel C-3 N-urea, amide, and carbamate dihydroindazolo[5,4-a]pyrrolo[3,4-c]carbazole analogs as potent TIE-2 and VEGF-R2 dual inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(20). 5368–5372. 13 indexed citations
5.
Tripathy, Rabindranath, Mohamed Iqbal, J. B. Singh, et al.. (2006). Structure-guided identification of novel VEGFR-2 kinase inhibitors via solution phase parallel synthesis. Bioorganic & Medicinal Chemistry Letters. 16(8). 2158–2162. 88 indexed citations
6.
Dobrzański, Paweł, Elizabeth O. Hexner, Cynthia Serdikoff, et al.. (2006). CEP-701 Is a JAK2 Inhibitor Which Attenuates JAK2/STAT5 Signaling Pathway and the Proliferation of Primary Cells from Patients with Myeloproliferative Disorders.. Blood. 108(11). 3594–3594. 17 indexed citations
7.
Kee, Anthony J., Galina Schevzov, Visalini Nair‐Shalliker, et al.. (2004). Sorting of a nonmuscle tropomyosin to a novel cytoskeletal compartment in skeletal muscle results in muscular dystrophy. The Journal of Cell Biology. 166(5). 685–696. 53 indexed citations
9.
Ruggeri, Bruce, Candy Robinson, Thelma S. Angeles, John Wilkinson, & Margie L. Clapper. (2002). The chemopreventive agent oltipraz possesses potent antiangiogenic activity in vitro, ex vivo, and in vivo and inhibits tumor xenograft growth.. PubMed. 8(1). 267–74. 33 indexed citations
10.
Robinson, Candy, et al.. (1998). Transcription occurs in pulses in muscle fibers. Genes & Development. 12(17). 2748–2758. 166 indexed citations
11.
Joya, Josephine E., et al.. (1998). Identification of a Novel Slow-Muscle-Fiber Enhancer Binding Protein, MusTRD1. Molecular and Cellular Biology. 18(11). 6641–6652. 71 indexed citations
13.
Kerr, Janet S., Hui-Yin Li, Roseanne S. Wexler, et al.. (1997). THE CHARACTERIZATION OF POTENT NOVEL WARFARIN ANALOGS. Thrombosis Research. 88(2). 127–136. 9 indexed citations
14.
Robinson, Candy, et al.. (1995). Cryo-immunogold ultrastructural localization of laminin in adult rat peripheral nerve. Journal of Neurocytology. 24(2). 79–84. 4 indexed citations
15.
Higley, C. Anne, Richard G. Wilde, Thomas Maduskuie, et al.. (1994). Acyl CoA:Cholesterol Acyltransferase (ACAT) Inhibitors: Synthesis and Structure-Activity Relationship Studies of a New Series of Trisubstituted Imidazoles. Journal of Medicinal Chemistry. 37(21). 3511–3522. 28 indexed citations
16.
Kinter, Michael, et al.. (1994). Whole Blood and Plasma Concentrations of 4-Hydroxy-2-nonenal in Watanabe Heritable Hyperlipidemic Versus New Zealand White Rabbits. Biochemical and Biophysical Research Communications. 199(2). 671–675. 9 indexed citations
18.
Gillies, Peter J., et al.. (1989). Effect of lanthanum chloride on established atherosclerosis in the cholesterol-fed rabbit. Mitral valve as a site for assessment of treatment effects.. Arteriosclerosis An Official Journal of the American Heart Association Inc. 9(2). 253–260. 8 indexed citations
19.
Gillies, Peter J. & Candy Robinson. (1988). Decreased plasma membrane fluidity in the development of atherosclerosis in cholesterol-fed rabbits. Atherosclerosis. 70(1-2). 161–164. 19 indexed citations
20.
Wagner, Róger & Candy Robinson. (1983). High-voltage electron microscopy of capillary endothelial vesicles. Proceedings annual meeting Electron Microscopy Society of America. 41. 470–471. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026